PROFOUND MEDICAL CORP. Deferred Income Tax Expense (Benefit)
PROFOUND MEDICAL CORP. (PROF) reported Deferred Income Tax Expense (Benefit) of -$13.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-06
- PROFOUND MEDICAL CORP. deferred income tax expense (benefit) for the quarter ending 2026-06-30 was -$13.00K.
- PROFOUND MEDICAL CORP. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was -$2.00K.
- PROFOUND MEDICAL CORP. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $14.00K.
- PROFOUND MEDICAL CORP. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $21.00K.
- PROFOUND MEDICAL CORP. deferred income tax expense (benefit) for fiscal 2025 was $21.00K.
- PROFOUND MEDICAL CORP. deferred income tax expense (benefit) for fiscal 2024 was -$146.00K, a 347.46% decline from fiscal 2023.
- PROFOUND MEDICAL CORP. deferred income tax expense (benefit) for fiscal 2023 was $59.00K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$13.00K 10-Q · filed 2026-08-06 | -$15.00K 10-Q · filed 2026-08-06 | -$1.00K derived: sum of 3 quarters · filed 2026-08-06 | $20.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$2.00K 10-Q · filed 2026-05-07 | $12.00K derived: sum of 2 quarters · filed 2026-05-07 | $33.00K derived: sum of 3 quarters · filed 2026-05-07 | $19.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $35.00K derived: sum of 2 quarters · filed 2026-03-05 | $21.00K derived: sum of 3 quarters · filed 2026-08-06 | $21.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $21.00K 10-Q · filed 2025-11-13 | $7.00K derived: sum of 2 quarters · filed 2026-08-06 | $7.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$14.00K 10-Q · filed 2026-08-06 | -$14.00K 10-Q · filed 2026-08-06 | ||
| 2024-12-31 | -$146.00K 10-K · filed 2026-03-05 | |||
| 2023-12-31 | $59.00K 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |